Certara announced that it has formed a strategic collaboration with Hedera Hashgraph. Synchrogenix, Certara’s regulatory sciences division, has been building distributed applications in the life sciences and healthcare markets that will expand its reach in the areas of transparency and disclosure, regulatory reporting and data sharing, and collaboration/communications from drug development through market access. Synchrogenix has already developed a proof of concept (POC) in industry supply chain management in collaboration with Hedera. This POC is centered on the global challenge of drug shortages, which have recently been prominent in the news due to a number of quality and supply issues. This type of near-real time information availability and transparent flow of critical supply data is vital for informed risk management and better responsiveness to stakeholders. The life sciences industry is premised on creating treatments and making them readily available to the people who need them. Synchrogenix has long supported the life sciences and healthcare industries by providing technology solutions for managing regulatory requirements, stakeholder communications, and transparency and disclosure requirements.